Abstract
Trisomy 21 (T21), given the third copy of cromosome 21, is marked by an altered gene expression that leads to a chronic inflammatory state and higher predisposal to several diseases. A promising way to minimize the impacts caused by this imbalance is to modulate the expression of genes associated with such diseases. The aim of this project is to characterize the inflammatory response and …